about
Grant application review: the case of transparencyRGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining.BDNF Val66Met polymorphism and protein levels in amniotic fluidErbB3 mRNA leukocyte levels as a biomarker for major depressive disorderAltered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood.Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis.Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.Microarray gene and miRNA expression studies: looking for new therapeutic targets for frontotemporal lobar degeneration.Insulin-like Growth Factor 1 Differentially Affects Lithium Sensitivity of Lymphoblastoid Cell Lines from Lithium Responder and Non-responder Bipolar Disorder Patients.Molecular signature of disease onset in granulin mutation carriers: a gene expression analysis study.RNA-sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium's clinical efficacy.The role of GRIK4 gene in treatment-resistant depression.MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder.Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment.Nanomedicine in Psychiatry: New Therapeutic Opportunities from Research on Small RNAs.Insulin-like growth factor binding protein 2 in bipolar disorder: An expression study in peripheral tissues.Gene expression profile of endoscopically active and inactive ulcerative colitis: preliminary data.Mucosal CCR1 gene expression as a marker of molecular activity in Crohn's disease: preliminary data.SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease.A gene co-expression module implicating the mitochondrial electron transport chain is associated with long-term response to lithium treatment in bipolar affective disorderCopy number variants in attention-deficit hyperactive disorderDifferential Intestinal Mucosa Transcriptomic Biomarkers for Crohn's Disease and Ulcerative ColitisUnderstanding phenotype variability in frontotemporal lobar degeneration due to granulin mutationMucosal gene expression changes induced by anti-TNF treatment in inflammatory bowel disease patientsmiR-146a and miR-181a are involved in the progression of mild cognitive impairment to Alzheimer's disease
P50
Q24288795-CBDF52E4-4F6B-406F-87A0-CBA098E6D1F9Q31134674-FF52BB12-CEE5-4D22-A37F-DCDDE712D50CQ33530233-D9D50A7E-391C-4974-962C-6D2CAC586F67Q34417778-F43E4F59-7867-42E8-9B56-10265077E314Q35058307-D7BDFF6E-DF85-456E-9A02-C2B8ECA3A5EBQ36901174-94497D18-A53E-4A9D-8B1F-F8776C20561DQ37347446-3A94162E-1528-49E4-B59F-3E69832B0B1EQ38246624-48FE35A5-5FF9-4E21-AFE4-EF4C5D9218EFQ38903498-ECD66B14-8FFD-4348-A707-A1CB204E0F01Q39465360-723B707B-40C8-4599-B0AF-70318CE48C9FQ40064656-C36A5879-DF70-4648-A306-07E83202AD47Q40772254-2A7C063A-02DC-4A75-BAAC-6DBCCC814D82Q40892445-07EBE28F-03CA-4373-8D1D-1B4879CAFD01Q43260112-FCCFD7E0-C59C-4FD6-9044-C5A926CFAEE8Q47936792-7DD8E74B-D437-4C89-B5DB-52D32F8BC98EQ47992428-96B6C9FA-8CC4-4077-A78C-2E1CC97E5EDFQ54133363-CDED34DB-5489-43CE-A7E0-167D197F5200Q54133370-333F6305-F431-49C7-A8F8-7259627CED87Q54958137-D774CA74-BC89-444A-BCE8-33880F8957E7Q57077038-49CA73E6-8E37-438C-898E-D665CF1C0CF3Q57399677-D12602BB-6969-41D7-B458-F1DB010745EBQ58699536-455182F6-BCBF-4417-B7EE-50A2B0B12A2EQ60050785-C91B1A88-7CA5-49F0-B1A8-1E56171515E7Q92019069-A9F4BEC7-FB50-492A-8DB8-17658A7CF337Q92776953-46416CF7-823D-48A4-BAB2-0726DA86F9D0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elena Milanesi
@ast
Elena Milanesi
@en
Elena Milanesi
@es
Elena Milanesi
@nl
type
label
Elena Milanesi
@ast
Elena Milanesi
@en
Elena Milanesi
@es
Elena Milanesi
@nl
prefLabel
Elena Milanesi
@ast
Elena Milanesi
@en
Elena Milanesi
@es
Elena Milanesi
@nl
P106
P108
P1153
35094446000
P21
P31
P496
0000-0003-2753-3395